NEJM:灼烧样腿痛-病例报道

2020-07-23 MedSci原创 MedSci原创

患者为一名24岁妇女,因严重的灼烧样腿痛2天而到门诊就诊。她既往有先天性感染人类免疫缺陷病毒的病史,为此服用了替诺福韦恩、曲他滨和洛匹那韦-利托那韦。就诊前4天,她还开始每天两次服用麦角胺治疗偏头痛。

患者为一名24岁妇女,因严重的灼烧样腿痛2天而到门诊就诊。她既往有先天性感染人类免疫缺陷病毒的病史,为此服用了替诺福韦恩、曲他滨和洛匹那韦-利托那韦。就诊前4天,她还开始每天两次服用麦角胺治疗偏头痛。

腿部疼痛从脚趾扩展到大腿中部,并伴有脚部变色和行走困难。检查时,双腿均发冷,腘窝和足背脉搏难以触及。计算机断层扫描(CT)血管造影检查发现双腿外动脉下方的动脉弥漫性、对称性管腔狭窄(如图A所示),怀疑为麦角中毒。

利托那韦抑制CYP3A4酶,导致血清麦角胺水平升高,从而引起肢体血管痉挛性缺血。该患者开始接受静脉注射前列腺素和普通肝素治疗。患者疼痛减轻,腿变暖,但由于坏疽,她左侧第二脚趾被截肢。

就诊后2周进行重复CT血管造影发现双腿灌注明显改善(如图B所示)。

原始出处:

Aravind Reghukumar,et al.Burning Pain in the Legs.N Engl J Med 2020;https://www.nejm.org/doi/full/10.1056/NEJMicm1911089

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=804255, encodeId=1d36804255b2, content=长见识了, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c9a2254373, createdName=1216f9c2m26暂无昵称, createdTime=Fri Jul 24 09:20:40 CST 2020, time=2020-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804183, encodeId=a97c8041834a, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/5b0fca0db0bc45e4bbf5856776fdbac3/55b6fae4b2364aeeb492b1a4cf33dce0.jpg, createdBy=04ad5379290, createdName=ms1000001793617395, createdTime=Thu Jul 23 20:59:03 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804140, encodeId=033280414099, content=<a href='/topic/show?id=ae37204e848' target=_blank style='color:#2F92EE;'>#不良事件#</a>这是抗病毒🦠药物的少见的不良反应非常值得关注。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20478, encryptionId=ae37204e848, topicName=不良事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Jul 23 16:15:40 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035356, encodeId=315b103535614, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Jul 23 16:15:08 CST 2020, time=2020-07-23, status=1, ipAttribution=)]
    2020-07-24 1216f9c2m26暂无昵称

    长见识了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=804255, encodeId=1d36804255b2, content=长见识了, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c9a2254373, createdName=1216f9c2m26暂无昵称, createdTime=Fri Jul 24 09:20:40 CST 2020, time=2020-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804183, encodeId=a97c8041834a, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/5b0fca0db0bc45e4bbf5856776fdbac3/55b6fae4b2364aeeb492b1a4cf33dce0.jpg, createdBy=04ad5379290, createdName=ms1000001793617395, createdTime=Thu Jul 23 20:59:03 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804140, encodeId=033280414099, content=<a href='/topic/show?id=ae37204e848' target=_blank style='color:#2F92EE;'>#不良事件#</a>这是抗病毒🦠药物的少见的不良反应非常值得关注。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20478, encryptionId=ae37204e848, topicName=不良事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Jul 23 16:15:40 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035356, encodeId=315b103535614, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Jul 23 16:15:08 CST 2020, time=2020-07-23, status=1, ipAttribution=)]
    2020-07-23 ms1000001793617395

    值得关注

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=804255, encodeId=1d36804255b2, content=长见识了, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c9a2254373, createdName=1216f9c2m26暂无昵称, createdTime=Fri Jul 24 09:20:40 CST 2020, time=2020-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804183, encodeId=a97c8041834a, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/5b0fca0db0bc45e4bbf5856776fdbac3/55b6fae4b2364aeeb492b1a4cf33dce0.jpg, createdBy=04ad5379290, createdName=ms1000001793617395, createdTime=Thu Jul 23 20:59:03 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804140, encodeId=033280414099, content=<a href='/topic/show?id=ae37204e848' target=_blank style='color:#2F92EE;'>#不良事件#</a>这是抗病毒🦠药物的少见的不良反应非常值得关注。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20478, encryptionId=ae37204e848, topicName=不良事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Jul 23 16:15:40 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035356, encodeId=315b103535614, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Jul 23 16:15:08 CST 2020, time=2020-07-23, status=1, ipAttribution=)]
    2020-07-23 heli0118

    #不良事件#这是抗病毒🦠药物的少见的不良反应非常值得关注。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=804255, encodeId=1d36804255b2, content=长见识了, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c9a2254373, createdName=1216f9c2m26暂无昵称, createdTime=Fri Jul 24 09:20:40 CST 2020, time=2020-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804183, encodeId=a97c8041834a, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/5b0fca0db0bc45e4bbf5856776fdbac3/55b6fae4b2364aeeb492b1a4cf33dce0.jpg, createdBy=04ad5379290, createdName=ms1000001793617395, createdTime=Thu Jul 23 20:59:03 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804140, encodeId=033280414099, content=<a href='/topic/show?id=ae37204e848' target=_blank style='color:#2F92EE;'>#不良事件#</a>这是抗病毒🦠药物的少见的不良反应非常值得关注。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20478, encryptionId=ae37204e848, topicName=不良事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Jul 23 16:15:40 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035356, encodeId=315b103535614, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Jul 23 16:15:08 CST 2020, time=2020-07-23, status=1, ipAttribution=)]
    2020-07-23 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0